AliveCor QT Service vs RhythmAnalytics
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary concern is precisely monitoring QT and QTc intervals to assess cardiac safety, particularly when prescribing or managing medications known to affect these intervals. This tool is ideal for healthcare professionals who utilize AliveCor 6-Lead ECG devices and require instant, accurate measurements to inform critical medication decisions.
View AliveCor QT Service →Choose RhythmAnalytics if…
Choose RhythmAnalytics if you need an AI-powered solution for automated, comprehensive interpretation of a wide range of cardiac arrhythmias from various single-lead ECG devices. This tool is best suited for healthcare professionals or integrators seeking robust clinical decision support for arrhythmia detection across different monitoring platforms, including Holter, event recorders, and wearable sensors.
View RhythmAnalytics →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | RhythmAnalytics |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact vendor |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Cloud-based API |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AliveCor QT ServiceTool A, AliveCor QT Service, integrates with user-facing applications like the KardiaStation app and KardiaPro portal, suggesting a more direct and accessible user experience for healthcare professionals. Tool B, RhythmAnalytics, is primarily a cloud-based API, meaning its direct usability is dependent on integration partners' interfaces rather than a standalone application for end-users.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value through AI-powered ECG analysis. Tool A specializes in critical QT and QTc interval measurements for cardiac safety and medication decisions, while Tool B provides broader automated interpretation of over 15 types of cardiac arrhythmias. The specific clinical value depends on the particular need, making a definitive winner difficult to determine.
Pricing & Value
TieNeither Tool A nor Tool B provides transparent pricing information, both stating 'Contact vendor for pricing details.' Without access to pricing structures, it is impossible to conduct a meaningful comparison of their value propositions.
Enterprise Readiness
AliveCor QT ServiceTool A explicitly confirms it 'has_baa':'1' (Business Associate Agreement), which is crucial for enterprise deployments handling Protected Health Information (PHI). While both are HIPAA compliant and FDA cleared, Tool B's BAA status is unspecified, and Tool A also lists a broader range of integration targets including EHR, SDK, CRM, EDC, and PSP platforms.
Innovation
TieBoth tools demonstrate strong innovation by leveraging AI and deep neural networks for cloud-based Software as a Medical Device (SaMD) in cardiac analysis. Tool A's focus on 'instant' QT/QTc measurements from ambulatory ECGs is a specialized application, while Tool B's detection of 'over 15 types of cardiac arrhythmias' represents broad, cutting-edge capability. Neither presents a clear, superior innovative edge.
Support & Docs
TieBoth companies are established providers of FDA-cleared healthcare AI solutions, implying robust support and documentation for their professional clientele. AliveCor offers a 'Resource Hub' and 'KardiaPro Support' for its users, while Biofourmis, as an enterprise API solution, would provide comprehensive support and documentation for its integrators and partners. Without specific comparative details on the quality or accessibility of these resources, a tie is appropriate.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | RhythmAnalytics |
|---|---|---|
| Name | AliveCor QT Service | RhythmAnalytics |
| Company | AliveCor | Biofourmis Singapore Pte. |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | RhythmAnalytics by Biofourmis is an FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. |
| Key Features | Cloud-based Software as a Medical Device (SaMD), Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Provides instant QT measurements (as InstantQT), Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms | AI-based automated interpretation of cardiac arrhythmias, Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats), Beat-by-beat morphology computation, ECG signal processing and analysis, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis, Cloud-based API for integration, Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors) |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and RhythmAnalytics.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or RhythmAnalytics
Backers
Who funded each tool's parent company.